Journal of the American Chemical Society
Page 12 of 15
(13) Lutker, K. M.; Tolstyka, Z. P.; Matzger, A. J. Investigation
Acknowledgements
of a Privileged Polymorphic Motif: A Dimeric ROY Derivative. Cryst.
(14) Price, S. L. From Crystal Structure Prediction to Polymorph
Prediction: Interpreting the Crystal Energy Landscape. Phys. Chem.
(15) Kennedy, S. R.; Jones, C. D.; Yufit, D. S.; Nicholson, C. E.;
Cooper, S. J.; Steed, J. W. Tailored Supramolecular Gel and Micro-
emulsion Crystallization Strategies – Is Isoniazid Really Monomor-
1
2
3
4
5
6
7
8
We thank the Engineering and Physical Sciences Research
Council for a project grant (EP/R013373/1). We acknowledge
the use of the IRIDIS High Performance Computing Facility,
and associated support services at the University of Southamp-
ton, in the completion of this work. Via CRT and GMD’s mem-
bership of the UK's HEC Materials Chemistry Consortium,
which is funded by EPSRC (EP/L000202, EP/R029431), this
work used the ARCHER UK National Supercomputing Service
(http://www.archer.ac.uk).
phic?
CrystEngComm
2018,
20,
1390–1398.
https://doi.org/10.1039/C8CE00066B.
(16) Zhang, K.; Fellah, N.; Shtukenberg, A. G.; Fu, X.; Hu, C.;
Ward, M. D. Discovery of New Polymorphs of the Tuberculosis Drug
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
We thank Dr Dmitry S. Yufit, the Department of Chemistry,
Durham University, UK for assistance with diffraction meas-
urements, and Dr Charlie McMonagle, Chemistry, Newcastle
University, UK for assistance with the high-pressure experi-
ments. We thank Prof. Mike Ward, New York University, USA
for provision of PXRD data of Form III of isoniazid for com-
parison.
Isoniazid.
CrystEngComm
2020,
22,
2705–2708.
https://doi.org/10.1039/D0CE00440E.
(17) Kuhnert‐Brandstätter, M. Thermomicroscopy in the Analysis
of Pharmaceuticals; International Series of Monographs in Analytical
Chemistry; Pergamon Press: Oxford, 1971; Vol. 45.
(18) Cruz-Cabeza, A. J.; Reutzel-Edens, S. M.; Bernstein, J.
Facts and Fictions about Polymorphism. Chem. Soc. Rev. 2015, 44,
(19) Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Por-
ter, W.; Morris, J. Ritonavir: An Extraordinary Example of Conforma-
tional Polymorphism. Pharm. Res. 2001, 18, 859–866.
(20) Mortazavi, M.; Hoja, J.; Aerts, L.; Quéré, L.; van de Streek,
J.; Neumann, M. A.; Tkatchenko, A. Computational Polymorph
Screening Reveals Late-Appearing and Poorly-Soluble Form of Rotig-
0181-9.
(21) Neumann, M. A.; Van De Streek, J.; Fabbiani, F. P. A. A.;
Hidber, P.; Grassmann, & O.; Grassmann, O. Combined Crystal Struc-
ture Prediction and High-Pressure Crystallization in Rational Pharma-
ceutical Polymorph Screening. Nat. Comm. 2015, 6, 7793.
References
(1)
Bučar, D. K.; Lancaster, R. W.; Bernstein, J. Disappearing
Polymorphs Revisited. Angew. Chem. Int. Ed. 2015, 54, 6972–6993.
(2)
Polymorphism, What It Is and How to Identify It: A Systematic Re-
view. RSC Adv. 2013, 3, 16905–16931.
(3) Bernstein, J. Polymorphism in Molecular Crystals; Oxford
University Press, 2002.
Brog, J.-P. P.; Chanez, C.-L. L.; Crochet, A.; Fromm, K. M.
(4)
Hilfiker, R. Polymorphism: In the Pharmaceutical Industry;
Hilfiker, R., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim,
FRG, 2006.
(22) Arlin, J.-B. B.; Price, L. S.; Price, S. L.; Florence, A. J. A
Strategy for Producing Predicted Polymorphs: Catemeric Carbamaze-
(5)
Su, C. S.; Liao, C. Y.; Jheng, W. De. Particle Size Control
pine
Form
V.
Chem.
Comm.
2011,
47,
7074.
and Crystal Habit Modification of Phenacetin Using Ultrasonic Crys-
tallization. Chem. Eng. Technol. 2015, 38, 181–186.
(23) Potticary, J.; Terry, L. R.; Bell, C.; Papanikolopoulos, A. N.;
Christianen, P. C. M.; Engelkamp, H.; Collins, A. M.; Fontanesi, C.;
Kociok-Köhn, G.; Crampin, S.; Da Como, E.; Hall, S. R. An Unfore-
seen Polymorph of Coronene by the Application of Magnetic Fields
during Crystal Growth. Nat. Comm. 2016, 7, 11555.
(24) An, J.-H.; Kim, W.-S. Antisolvent Crystallization Using
Ionic Liquids As Solvent and Antisolvent for Polymorphic Design of
Active Pharmaceutical Ingredient. Cryst. Growth Des. 2013, 13, 31–
(6)
McCrone, W. C. Physics and Chemistry of the Organic Solid
State. In Physics and Chemistry of the Organic Solid State; Fox, D.,
Labes, M. M., Weissberger, A., Eds.; Wiley-Interscience: New York,
1965; Vol. 2, 725–767.
(7)
Bhardwaj, R. M.; McMahon, J. A.; Nyman, J.; Price, L. S.;
Konar, S.; Oswald, I. D. H.; Pulham, C. R.; Price, S. L.; Reutzel-Edens,
S. M. A Prolific Solvate Former, Galunisertib, under the Pressure of
Crystal Structure Prediction, Produces Ten Diverse Polymorphs. J. Am.
Chem.
(8) Zeidan, T. A.; Trotta, J. T.; Tilak, P. A.; Oliveira, M. A.;
Soc.
2019,
141,
13887–13897.
(25) Day, G. M. Current Approaches to Predicting Molecular Or-
ganic Crystal Structures. Crystallography Reviews 2011, 17, 3–52.
Chiarella, R. A.; Foxman, B. M.; Almarsson; Hickey, M. B. An Un-
precedented Case of Dodecamorphism: The Twelfth Polymorph of Ar-
ipiprazole Formed by Seeding with Its Active Metabolite.
CrystEngComm
(9) Levesque, A.; Maris, T.; Wuest, J. D. ROY Reclaims Its
Crown: New Ways to Increase Polymorphic Diversity. J. Am. Chem.
(10) Tyler, A. R.; Ragbirsingh, R.; McMonagle, C. J.; Waddell,
P. G.; Heaps, S. E.; Steed, J. W.; Thaw, P.; Hall, M. J.; Probert, M. R.
Encapsulated Nanodroplet Crystallization of Organic-Soluble Small
(26) Reilly, A. M.; Cooper, R. I.; Adjiman, C. S.; Bhattacharya,
S.; Boese, A. D.; Brandenburg, J. G.; Bygrave, P. J.; Bylsma, R.; Camp-
bell, J. E.; Car, R.; Case, D. H.; Chadha, R.; Cole, J. C.; Cosburn, K.;
Cuppen, H. M.; Curtis, F.; Day, G. M.; DiStasio Jr, R. A.; Dzyab-
chenko, A.; van Eijck, B. P.; Elking, D. M.; van den Ende, J. A.; Facelli,
J. C.; Ferraro, M. B.; Fusti-Molnar, L.; Gatsiou, C.-A.; Gee, T. S.; de
Gelder, R.; Ghiringhelli, L. M.; Goto, H.; Grimme, S.; Guo, R.; Hof-
mann, D. W. M.; Hoja, J.; Hylton, R. K.; Iuzzolino, L.; Jankiewicz, W.;
de Jong, D. T.; Kendrick, J.; de Klerk, N. J. J.; Ko, H.-Y.; Kuleshova,
L. N.; Li, X.; Lohani, S.; Leusen, F. J. J.; Lund, A. M.; Lv, J.; Ma, Y.;
Marom, N.; Masunov, A. E.; McCabe, P.; McMahon, D. P.; Meekes,
H.; Metz, M. P.; Misquitta, A. J.; Mohamed, S.; Monserrat, B.; Needs,
R. J.; Neumann, M. A.; Nyman, J.; Obata, S.; Oberhofer, H.; Oganov,
A. R.; Orendt, A. M.; Pagola, G. I.; Pantelides, C. C.; Pickard, C. J.;
Podeszwa, R.; Price, L. S.; Price, S. L.; Pulido, A.; Read, M. G.; Reuter,
K.; Schneider, E.; Schober, C.; Shields, G. P.; Singh, P.; Sugden, I. J.;
Szalewicz, K.; Taylor, C. R.; Tkatchenko, A.; Tuckerman, M. E.; Va-
carro, F.; Vasileiadis, M.; Vazquez-Mayagoitia, A.; Vogt, L.; Wang,
Y.; Watson, R. E.; de Wijs, G. A.; Yang, J.; Zhu, Q.; Groom, C. R.
2016,
18,
1486–1488.
Molecules.
Chem
2020,
6,
1755-1765.
(11) Braga, D.; Grepioni, F. Crystal Engineering: From Mole-
cules and Crystals to Materials; Springer Netherlands, 1999; 421–441.
(12) Uzoh, O. G.; Cruz-Cabeza, A. J.; Price, S. L. Is the Fenamate
Group a Polymorphophore? Contrasting the Crystal Energy Land-
scapes of Fenamic and Tolfenamic Acids. Cryst. Growth Des. 2012,
ACS Paragon Plus Environment